We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

480 hedge funds and large institutions have $6.97B invested in Jazz Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 183 increasing their positions, 160 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

14% more repeat investments, than reductions

Existing positions increased: 183 | Existing positions reduced: 160

0.86% more ownership

Funds ownership: 92% → 92.86% (+0.86%)

2% less capital invested

Capital invested by funds: $7.12B → $6.97B (-$152M)

4% less funds holding

Funds holding: 499 → 480 (-19)

18% less call options, than puts

Call options by funds: $19.5M | Put options by funds: $23.9M

21% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 68

Holders
480
Holders Change
-19
Holders Change %
-3.81%
% of All Funds
6.91%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
54
Increased
183
Reduced
160
Closed
68
Calls
$19.5M
Puts
$23.9M
Net Calls
-$4.39M
Net Calls Change
-$11.9M

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$175M
2
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
+$133M
3
CCM
Camber Capital Management
Massachusetts
+$58.2M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$53.9M
5
VPC
Vestal Point Capital
New York
+$45.9M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$128M
2
Swedbank
Swedbank
Sweden
-$127M
3
AC
Armistice Capital
New York
-$80.1M
4
Morgan Stanley
Morgan Stanley
New York
-$73.3M
5
Millennium Management
Millennium Management
New York
-$69.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
51
Samlyn Capital
New York
$23.8M -$52M -424,251 -68%
Aristotle Capital Management
52
Aristotle Capital Management
California
$23.7M -$32K -261 -0.1%
Grantham, Mayo, Van Otterloo & Co (GMO)
53
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$23.4M -$1.66M -13,558 -7%
Retirement Systems of Alabama
54
Retirement Systems of Alabama
Alabama
$23.4M +$2.59M +21,168 +12%
Goldman Sachs
55
Goldman Sachs
New York
$22.4M -$6.39M -52,158 -22%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$22.3M -$95.9K -783 -0.4%
Swiss National Bank
57
Swiss National Bank
Switzerland
$21.6M -$1.04M -8,500 -5%
UBS Group
58
UBS Group
Switzerland
$19.8M -$1.05M -8,547 -5%
Canada Pension Plan Investment Board
59
Canada Pension Plan Investment Board
Ontario, Canada
$19.5M +$4.64M +37,900 +31%
TRSOTSOK
60
Teachers Retirement System of the State of Kentucky
Kentucky
$19.4M +$6.16M +50,300 +45%
Sumitomo Mitsui Trust Group
61
Sumitomo Mitsui Trust Group
Japan
$19.2M -$382K -3,117 -2%
Deutsche Bank
62
Deutsche Bank
Germany
$17.8M -$1.87M -15,265 -9%
RPAM
63
Rhenman & Partners Asset Management
Sweden
$17.7M +$2.83M +23,095 +19%
Victory Capital Management
64
Victory Capital Management
Texas
$17.3M +$912K +7,445 +5%
CS
65
Credit Suisse
Switzerland
$17.3M +$1.26M +10,285 +8%
First Trust Advisors
66
First Trust Advisors
Illinois
$16.4M +$2.11M +17,219 +14%
Connor, Clark & Lunn Investment Management (CC&L)
67
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$15.8M -$6.45M -52,647 -29%
Federated Hermes
68
Federated Hermes
Pennsylvania
$15.4M +$1.07M +8,732 +7%
DZ Bank
69
DZ Bank
Germany
$15.3M +$8.54M +69,748 +121%
VA
70
Vident Advisory
Georgia
$15M +$4.33M +35,347 +40%
PCM
71
Philosophy Capital Management
California
$14.6M +$14.9M +121,313 New
Jane Street
72
Jane Street
New York
$14.4M -$19.4M -158,721 -57%
American Century Companies
73
American Century Companies
Missouri
$14.1M +$5.16M +42,106 +56%
DekaBank Deutsche Girozentrale
74
DekaBank Deutsche Girozentrale
Germany
$13.9M +$2.91M +23,768 +26%
RCMC
75
RK Capital Management (Colorado)
Colorado
$13.3M +$2.3M +18,800 +20%
1 2
3
4 5

JAZZ Hedge Fund Activity: Q1 2024 in Review

480 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q1 2024, worth a combined $6.97B — down 2.1% from $7.12B a quarter earlier.

Sellers outnumbered buyers: 68 funds closed out of JAZZ and 54 opened new positions — a net loss of 14 holders — while 160 trimmed existing stakes and 183 added.

The largest buyer was Capital World Investors, opening a new position worth an estimated $175M. The largest seller was Wellington Management Group, cutting an estimated $128M.

  • 480 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q1 2024, down from 499 in Q4 2023.
  • Funds reported $6.97B of Jazz Pharmaceuticals stock for Q1 2024, down 2.1% quarter-over-quarter.
  • 54 funds opened new Jazz Pharmaceuticals positions in Q1 2024 and 68 closed out, a net change of -14 holders.
  • The largest Jazz Pharmaceuticals buyer in Q1 2024 was Capital World Investors, an estimated $175M added.
  • The largest Jazz Pharmaceuticals seller in Q1 2024 was Wellington Management Group, an estimated $128M sold.

Based on aggregated 13F filings for Q1 2024.